GLP-1 is part of a group of hormones called incretins, which increases the release of insulin
(NOTE: This isn't a slam on either platform - I'm simply noting that people are going SOMEWHERE to figure out these things, and it isn't your plan documents or their doctor.) If youre not aware of this kind of 'off-label' use, youre missing a big part of the picture: People trying to save money People easing side effects People winging it on their own Its not just about whether you cover the drug (people are microdosing even when their employer covers the medication.) Its about how the care is managedand whether theres real support behind the prescription
This effect was completely abolished by additional treatment with 2 IU depot insulin/day
To remain compliant, compounding pharmacies must keep abreast of constantly changing and updating regulation from a variety of different regulatory agencies
Due to the formidable barrier posed by the SC, only a limited number of drugs are approved for transdermal delivery [228, 229]
That mayhem is collectively known as oxidative stress or oxidative damage
